TLOG (OTC)
TETRALOGIC PHARMS CORP
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- J. Kevin Buchi, MBA, CPA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.00M
- Employees
- 11
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2016 (Q1)
|
$-0.45 | $-0.41 | -0.0420 | -10.29% |
|
Dec 2015 (Q4)
|
$-0.58 | $-0.53 | -0.0547 | -10.41% |
|
Sep 2015 (Q3)
|
$-0.46 | $-0.43 | -0.0316 | -7.38% |
|
Jun 2015 (Q2)
|
$-0.51 | $-0.47 | -0.0357 | -7.53% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $36.53M |
| Depreciation and Amortization | $152.33K |
| Other Operating Expenses | $8.97M |
| Operating Income/Loss | -$36.53M |
| Income/Loss From Continuing Operations After Tax | -$40.69M |
| Income/Loss From Continuing Operations Before Tax | -$43.01M |
| Interest Expense, Operating | $6.80M |
| Net Income/Loss | -$40.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$40.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$40.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.65 |
| Diluted Earnings Per Share | -$1.65 |
| Basic Average Shares | 49,901,029 |
| Diluted Average Shares | 49,899,199 |
| Assets | $42.79M |
| Current Assets | $6.37M |
| Noncurrent Assets | $36.41M |
| Fixed Assets | $7.46K |
| Intangible Assets | $36.41M |
| Liabilities | $73.73M |
| Current Liabilities | $13.33M |
| Accounts Payable | $241.63K |
| Other Current Liabilities | $13.09M |
| Noncurrent Liabilities | $60.39M |
| Equity | -$30.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$30.94M |
| Liabilities And Equity | $42.79M |
| Net Cash Flow From Operating Activities | -$23.88M |
| Net Cash Flow From Operating Activities, Continuing | -$23.88M |
| Net Cash Flow From Investing Activities | $13.78M |
| Net Cash Flow From Investing Activities, Continuing | $13.78M |
| Net Cash Flow From Financing Activities | $11.22K |
| Net Cash Flow From Financing Activities, Continuing | $11.22K |
| Exchange Gains/Losses | $78.49K |
| Net Cash Flow | -$10.02M |
| Net Cash Flow, Continuing | -$10.10M |
| Comprehensive Income/Loss | -$40.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.76M |
| Other Comprehensive Income/Loss | -$40.76M |